Effect of inhaled corticosteroid therapy in pulmonary sarcoidosis patients who manifest airflow limitatio
Not Applicable
Recruiting
- Conditions
- Pulmonary sarcoidosis patients who revealed airflow limitation in peak flow tests, increased respiratory resistance in IOS, or increased WA% in HRCT.
- Registration Number
- JPRN-UMIN000013831
- Lead Sponsor
- Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. patients with heart failure 2. patients with renal failure 3. patients with past hisotry of bronchial asthma 4. ex, or current smokers 5. patients with pulmonary disease except for pulmonary sarcoidosis 6. patients whose participations in this study are thought to be inappropriate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method